1. Home
  2. CLLS vs WEYS Comparison

CLLS vs WEYS Comparison

Compare CLLS & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • WEYS
  • Stock Information
  • Founded
  • CLLS 1999
  • WEYS 1906
  • Country
  • CLLS France
  • WEYS United States
  • Employees
  • CLLS N/A
  • WEYS N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • CLLS Health Care
  • WEYS Consumer Staples
  • Exchange
  • CLLS Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • CLLS 299.0M
  • WEYS 294.5M
  • IPO Year
  • CLLS 2007
  • WEYS N/A
  • Fundamental
  • Price
  • CLLS $3.79
  • WEYS $29.33
  • Analyst Decision
  • CLLS Buy
  • WEYS
  • Analyst Count
  • CLLS 1
  • WEYS 0
  • Target Price
  • CLLS $4.00
  • WEYS N/A
  • AVG Volume (30 Days)
  • CLLS 151.7K
  • WEYS 13.7K
  • Earning Date
  • CLLS 11-03-2025
  • WEYS 11-04-2025
  • Dividend Yield
  • CLLS N/A
  • WEYS 3.71%
  • EPS Growth
  • CLLS N/A
  • WEYS N/A
  • EPS
  • CLLS N/A
  • WEYS 2.69
  • Revenue
  • CLLS $63,438,000.00
  • WEYS $281,051,000.00
  • Revenue This Year
  • CLLS N/A
  • WEYS N/A
  • Revenue Next Year
  • CLLS $66.76
  • WEYS N/A
  • P/E Ratio
  • CLLS N/A
  • WEYS $10.91
  • Revenue Growth
  • CLLS 223.09
  • WEYS N/A
  • 52 Week Low
  • CLLS $1.10
  • WEYS $25.51
  • 52 Week High
  • CLLS $3.83
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 65.98
  • WEYS 43.03
  • Support Level
  • CLLS $3.36
  • WEYS $29.61
  • Resistance Level
  • CLLS $3.60
  • WEYS $30.41
  • Average True Range (ATR)
  • CLLS 0.24
  • WEYS 0.91
  • MACD
  • CLLS 0.02
  • WEYS -0.07
  • Stochastic Oscillator
  • CLLS 96.95
  • WEYS 2.25

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: